|Articles|June 1, 1999

Clinical and Economic Impact of Breast Cancer Treatment and Prevention in High-Risk Women
Volume 5
Issue 6 Suppl

Breast Cancer Stage Cost Analysis in a Managed Care Population

Author(s)Kenneth L. McDonough, MD

Download PDF: Breast Cancer Stage Cost Analysis in a Managed Care Population

Articles in this issue

over 26 years ago

Article

The Economics and Challenges of Breast Cancer in a Managed Care Environment

over 26 years ago

Article

Participating Faculty

over 26 years ago

Article

Medical and Economic Impact of Breast Cancer Treatment and Prevention

over 26 years ago

Article

Benefits Foregone: Too Much of the Wrong and Too Little of the Right

over 26 years ago

Article

Breast Cancer: Overview of Current Management Considerations of Economic Impact

over 26 years ago

Article

Breast Cancer Epidemiology: An Overview

over 26 years ago

Article

Overview of Cancer Economics

over 26 years ago

Article

The Cost Effectiveness of Tamoxifen in the Prevention of Breast Cancer

over 26 years ago

Article

Question-and-Answer Session

over 26 years ago

Article

Selected Abstracts

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

ByNate C. Apathy, PhD

January 27th 2026

Building Trust: Public Priorities for Health Care AI Labeling

ByMorgan L. Sielaff, BS,Jodyn Platt, PhD, MPH,Sean Tan, MPP,Kerry A. Ryan, MA,Paige Nong, PhD,Sharon L. R. Kardia, PhD

January 27th 2026

Ambient AI Tool Adoption in US Hospitals and Associated Factors

ByFreddie Yang, MA,Ilana Graetz, PhD

January 27th 2026

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

ByTaylor I. Bucy, PhD,John P. McHugh, PhD,Dori A. Cross, PhD

January 26th 2026

Specialty and Operator Status Influence Electronic Health Record Use Variation

ByPhillip D. Jenkins, MD,Gary Grunkemeier, PhD,Elizabeth Weirich, DO,An Dinh, MS,Ruchi Thanawala, MD, MS,Jeffrey A. Gold, MD,Julie Doberne, MD, PhD

January 22nd 2026

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

Breast Cancer Stage Cost Analysis in a Managed Care Population

Articles in this issue

Newsletter

Related Content

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Building Trust: Public Priorities for Health Care AI Labeling

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Motivating and Enabling Factors Supporting Targeted Improvements to Hospital-SNF Transitions

Specialty and Operator Status Influence Electronic Health Record Use Variation

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Trending on AJMC

CMS Proposes Nearly Flat 2027 Medicare Advantage Payment Rates

ICE Presence in Minnesota Health Care Settings Threatens Access to Essential Medical Care

AAP Breaks With CDC, Maintains Broader 2026 Childhood and Adolescent Vaccine Schedule

Experts Warn CDC Childhood Immunization Schedule Revisions Could Reduce Uptake, Erode Public Trust

New Dermatologic Therapies Make Waves at Maui Derm 2026